Hao Zeng
West China Hospital
Emerging Leaders
#3328 pts
Current Leaders
#81213 pts
All-Time Leaders
#41628 pts
Scored by the scientific impact (publications, citations, press) of the trials they lead, weighted by role. First trial 2021. 7 trials as lead/chair. How it works →
Trials led — by scientific impact
Single-arm Phase II Clinical Trial to Evaluate the Initial Efficacy and Safety of Sintilimab Injection Combined With Inlyta in Fumarate Hydratase- Deficient Renal Cell Carcinoma
Phase 2UnknownWest China Hospital
6
impact
A Single-center, Phase II Neoadjuvant Study of Abiraterone Acetate in the Treatment of Intraductal Carcinoma of the Prostate
Phase 2UnknownWest China Hospital
6
impact
A Multicenter, Prospective, Randomized Controlled Phase II Trial of PSMA PET/CT-Guided Stereotactic Body Radiotherapy Combined With Darolutamide and Androgen Deprivation Therapy in Patients With Metastatic Hormone-Sensitive Prostate Cancer
Phase 2Not Yet RecruitingWest China Hospital
5
impact
Phase Ib/II Clinical Study of TQB3616 Capsules in Combination With Abiraterone Acetate Plus Prednisone in Patients With Metastatic Castration-Resistant Prostate Cancer
Phase 2UnknownWest China Hospital
4
impact
Efficacy and Safety of First-Line Cadonilimab Plus Axitinib in Patients With Advanced Special Pathological Type Renal Cell Carcinoma: A Prospective, Multi-center, Phase Ib/II Trial
Phase 2ActiveHao Zeng
4
impact
A Multicenter Phase II Study of RC48-ADC in Adjuvant/Salvage Treatment of HER2 Positive High-risk Non-muscle-invasive Bladder Cancer
Phase 2Not Yet RecruitingWest China Hospital
2
impact
A Multi-omics Study of Metastatic Prostate Cancer (MOSMPCA)
N/AUnknownWest China Hospital
0
impact